Semaglutide vs Tirzepatide: Compare Weight Loss, Side Effects, and Cost
Tirzepatide usually wins on average weight-loss data, semaglutide is the lower-cost self-pay option inside MeAgain, and the same tracker app works for either weekly shot. Semaglutide works on one GLP-1 pathway and stays in the body for about a week, while tirzepatide works on two pathways and tapers a little faster at about 5 days. MeAgain is the purpose-built app that helps you compare those paths and then track whichever one your doctor picks. The app includes the medication graph, a shot day checklist, last-site logging so you rotate injection spots, side effect tracking across 20 GLP-1 symptoms, five food logging methods, and the Capybara home screen widget. MeAgain has 286,000 users and a 4.8-star App Store rating across over 16,000 ratings. The app subscription is $9.99/month, and subscribers who want a self-pay path can also start compounded semaglutide at $123/month or compounded tirzepatide at $199/month through US-based 503A and 503B pharmacies after licensed clinician approval.
Key takeaways
- 1.Tirzepatide usually leads to bigger average weight-loss results in large studies, while semaglutide is the lower-cost self-pay option inside MeAgain. Both are once-weekly shots, and the same tracker app works for either one from day one through maintenance.
- 2.Semaglutide hangs around for about a week, while tirzepatide tapers a little faster at about 5 days. MeAgain's medication graph adjusts to either weekly curve, so you can see where your shot is rising, peaking, and fading between doses.
- 3.Semaglutide usually ramps through 5 dose steps and tirzepatide through 6. MeAgain keeps the current step, next shot countdown, last injection site, and symptom pattern in one place, which matters most when you are deciding whether to stay, pause, or switch.
- 4.MeAgain is the daily app layer behind the drug choice: 286,000 users, 4.8 stars, and over 16,000 ratings. The shot day checklist, side effect log, five food logging methods, and Capybara widget all work whether your doctor picks semaglutide or tirzepatide.
- 5.If you want a zero markup self-pay path inside the same app, subscribers can start compounded semaglutide at $123/month or compounded tirzepatide at $199/month after licensed clinician approval. The app subscription is $9.99/month, month-to-month, and medication ships from US-based 503A and 503B pharmacies.
What Makes MeAgain the Right App After You Choose Your Shot?
01One Medication Graph That Fits Either Weekly Shot
Most semaglutide vs tirzepatide explainers stop at the headline difference, but the lived difference shows up in the weekly curve. Semaglutide lingers for about a week. Tirzepatide tapers a little faster at about 5 days. MeAgain's medication graph switches between those two weekly shapes automatically based on the shot and dose you set. That means a semaglutide subscriber sees a longer fade, while a tirzepatide subscriber sees a slightly tighter weekly drop. The graph matters because appetite, thirst, food noise, and side effects often feel different on day 1 than on day 6. Instead of guessing why Thursday feels different than Monday, you can see where you are in the week. If you switch shots later, the graph changes with you without wiping out the rest of your log.
02Tracking the 5 Semaglutide Dose Steps and 6 Tirzepatide Dose Steps
One of the clearest practical differences between semaglutide and tirzepatide is the number of dose steps. Semaglutide for weight loss usually moves through 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg. Tirzepatide usually moves through 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. MeAgain keeps your current step, the next shot countdown, the last logged dose, and the notes around each increase together in one treatment view. That makes it much easier to answer the real question people ask in week 7 or week 15: should I stay where I am, step up, or give my body another week? The app does not make the medical decision for you, but it gives you the clean log you need when you talk with a licensed clinician.
03Side Effects and Daily Nutrition Logged the Same Way on Either Shot
People comparing semaglutide and tirzepatide usually want to know which one feels easier. Both can bring nausea, constipation, fatigue, heartburn, appetite suppression, and food aversion, and the answer often changes by dose step. MeAgain tracks 20 default GLP-1 symptoms on a 0-10 severity slider, then lets you layer those entries beside protein, water, fiber, meals, and weight. Over a few weeks, the pattern gets easier to read: maybe semaglutide felt steadier for you, or maybe tirzepatide gave stronger appetite control but pushed water intake lower on the first two days after a shot. Five food logging methods keep that nutrition log fast enough to use on real life days, not just perfect ones. Average study results are useful, but once treatment starts, your own symptom, meal, and weight patterns matter more.
04Switch From Semaglutide to Tirzepatide Without Starting Over
Many GLP-1 users do not stay on the first medication forever. Some start on semaglutide because the self-pay cost is lower, then move to tirzepatide later. Others step the other direction because side effects, availability, or budget change. MeAgain is built for that reality. Your weight trend, food log, symptom history, shot dates, journey photos, and daily targets stay in one timeline even if the medication changes. You do not have to start a new spreadsheet or lose the context from the first months of your journey. The only thing that changes is the treatment setup: shot, dose, and weekly curve. That continuity matters because the most useful comparison is rarely abstract. It is what happened in your own body before and after the switch.
Semaglutide vs Tirzepatide: What Actually Changes Week to Week
Semaglutide and tirzepatide are both once-weekly GLP-1-family shots used for long-term weight management, but they do not feel identical across the week. Semaglutide targets GLP-1 and usually lingers for about a week. Tirzepatide targets both GIP and GLP-1 and usually moves through the week a little faster, at about 5 days. In separate large obesity trials, semaglutide 2.4mg led to 14.9% mean weight loss at 68 weeks in STEP-1 (n=1,961), while tirzepatide 15mg led to 20.9% mean weight loss at 72 weeks in SURMOUNT-1 (n=2,539). Those were not head-to-head obesity trials, so they are useful for direction, not as a guarantee for any one person. The real choice is a tradeoff between average weight-loss strength, price, side effects, availability, and what your doctor thinks fits your history. MeAgain's role is not to pick the winner for you. It is to make either path easier to follow once the weekly shot becomes part of real life.
| Question | Semaglutide | Tirzepatide |
|---|---|---|
| How it works | One GLP-1 pathway | GIP + GLP-1 pathways |
| Weekly rhythm | Longer fade across about 7 days | Slightly faster fade across about 5 days |
| Large-trial weight-loss result | 14.9% mean loss at 68 weeks in STEP-1 | 20.9% mean loss at 72 weeks in SURMOUNT-1 |
| Top dose (weight loss) | 2.4mg weekly | 15mg weekly |
| Typical ramp length | 5-step path | 6-step path |
| MeAgain self-pay option | $123/month compounded semaglutide | $199/month compounded tirzepatide |
How to Think About the Choice
- If lower self-pay cost matters most, semaglutide is the cheaper in-app option.
- If stronger average weight-loss data matters most, tirzepatide leads in large studies.
- If you are worried about side effects, daily logging matters more than averages because tolerance is personal.
- Both are once-weekly shots, so shot day, injection-site rotation, protein, water, and symptom logging matter on either path.
- If you may switch later, pick the app that keeps the whole timeline intact instead of splitting your history across tools.
MeAgain makes money from the $9.99/month app subscription. That's it. That is why the tracker works whether you stay on semaglutide, move to tirzepatide, or change again later, and why the price you see inside the app is the most you will pay for MeAgain's zero markup self-pay medication path: $123/month for compounded semaglutide and $199/month for compounded tirzepatide, month-to-month, with no upfront commitment. Some people will still prefer an insurance-covered pen or another prescription route, and if that is your top priority, that path may be the better fit. MeAgain is built for subscribers who want the tracker first, with an optional self-pay path to either weekly shot inside the same app. Whichever shot you and your doctor choose, the tracker works for it, and if you want the self-pay route later, the in-app intake is available inside MeAgain.
This content is for informational purposes only and does not constitute medical advice. Drug choice, dose changes, and side-effect management should be decided with your doctor or licensed clinician. Brand-name products referenced here are made by Novo Nordisk or Eli Lilly; MeAgain's self-pay options are compounded preparations dispensed through US-based 503A and 503B pharmacies.
Sources
- Wilding JPH et al. - Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1, NEJM 2021, n=1,961)
- Jastreboff AM et al. - Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539)
- Frias JP et al. - Tirzepatide versus Semaglutide Once Weekly in a Type 2 Diabetes Study (SURPASS-2, NEJM 2021)
- Semaglutide Prescribing Information Reference (FDA, 2025)
- Tirzepatide Prescribing Information Reference (FDA, 2025)
- FDA - Compounded Drug Products: Section 503A and 503B Pharmacies
What Real Users Say When the Drug Choice Turns Into Daily Life
The Comparison Starts With the Drug. The Daily Work Starts After.
The drug comparison is useful, but daily life still comes down to water, fiber, meals, symptoms, and how the week felt after the last dose increase. One App Store reviewer put that daily rhythm better than any trial chart can: “This app has helped me on my journey! Track my water, fiber and calories! Helped me stay on track!!!” Once you start either weekly shot, the habits you can see every day matter most: water, fiber, protein, shot day, symptoms, and the weight trend over time.
MeAgain is the layer that stays useful after the semaglutide-vs-tirzepatide debate ends. The same app subscription covers the medication graph, shot day checklist, last-site tracking, side effect logging across 20 default GLP-1 symptoms, five food logging methods, and the Capybara widget keeping protein, water, fiber, and steps in view. If your doctor keeps you on semaglutide, the app fits. If your doctor later switches you to tirzepatide, the app still fits. That continuity keeps your full history in one place before and after a switch.
What Our Users Say
“Getting to chat with an AI capybara is a really cool feature. The photo taking feature to list food is pretty great, I took a picture of three eggs on a skillet with cheese and it even caught the cheese. My journey would not have been this successful without an app like this.”
“App is easy to use, has an extensive food database, and their customer support channel is wonderful! Highly recommend!”
“This app is so easy and motivates me to make healthy choices and stick with it. Customer service is amazing.”
“This app has helped me on my journey! Track my water, fiber and calories! Helped me stay on track!!!”
“Such a user friendly app that helps track all the essential information with no difficulty, helping me reach my target with ease.”
Semaglutide vs Tirzepatide - FAQs
Tirzepatide usually leads to bigger average weight-loss numbers, while semaglutide is the simpler single-pathway weekly shot and the lower-cost self-pay option inside MeAgain. Both are once-weekly GLP-1-family medications, but they do not feel identical week to week. Semaglutide stays in the body for about a week. Tirzepatide tapers a little faster at about 5 days and often brings stronger appetite suppression. In separate large obesity trials, semaglutide reached 14.9% mean weight loss at 68 weeks and tirzepatide reached 20.9% at 72 weeks, though those were not the same trial. The right choice depends on your goals, budget, side-effect pattern, and your doctor's view of your history. MeAgain helps by tracking either shot in the same app, so the weekly shot, symptom log, meals, and weight trend stay visible whichever path you choose.
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.